[Pulmonary fibrosis after busulfan therapy].
作者信息
Jandl H, Franke A, Albrecht G
出版信息
Z Gesamte Inn Med. 1975 Dec 15;30(24):799-801.
PMID:1062873
Abstract
After a short review concerning the side-effect of busulfan (myleran) a case of a myleran lung in a 45-year-old male patient is described who received altogether 408.0 mg myleran, as he suffered from a chronic myeloic leucosis; the special literature is cited and the developmental mechanisms are discussed.
摘要
相似文献
1
[Pulmonary fibrosis after busulfan therapy].
Z Gesamte Inn Med. 1975 Dec 15;30(24):799-801.
2
Busulfan lung.
Am J Dis Child. 1977 Jun;131(6):650-2.
3
[Busulfan lung. Pulmonary fibrosis caused by Myleran].
Med Welt. 1976 Feb 13;27(7):308-11.
4
[Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].
Union Med Can. 1977 Nov;106(11):1522-8.
5
[Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
Rev Med Chil. 1973 Jan;101(1):42-6.
6
[Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].
Schweiz Med Wochenschr. 1974 Aug 10;104(32):1115-9.
7
[Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
Arch Anat Pathol (Paris). 1972 Sep;20(3):291-4.
8
[Myleran lung in chronic myelosis].
Wien Z Inn Med. 1973;54(4):150-5.
9
[Busulfan lung (a case report) (author's transl)].
Rinsho Hoshasen. 1978 Oct;23(10):1047-51.
10
[Busulfan lung exacerbated during steroid therapy: a review of Japanese literature].
Rinsho Ketsueki. 1990 Nov;31(11):1884-8.
Zotero 插件